[
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-1",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#definitiongeneral306358",
    "clean_content": "Definition / general\n\n* Benign expansion of immature terminal deoxynucleotidyl transferase (TdT) positive T cells in extramedullary and extrathymic tissues* Can be seen concurrently with other hematologic disorders or epithelial malignancies, such as Castleman disease, follicular dendritic cell sarcomas, angioimmunoblastic T cell lymphoma, hepatocellular carcinoma, acinic cell carcinoma, etc."
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-2",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#essentialfeatures306359",
    "clean_content": "Essential features\n\n* Benign proliferation of extrathymic immature T cells that lack significant morphologic atypia but mimic malignant T lymphoblastic lymphoma / leukemia* Nonclonal process without evidence of TCR γ or β gene rearrangements* Lack of aberrant immunophenotypic or karyotypic abnormalities"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-3",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#terminology306360",
    "clean_content": "Terminology\n\n* Immature T lymphoblastic proliferation* iT-LBP"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-4",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#epidemiology306362",
    "clean_content": "Epidemiology\n\n* Age, gender, ethnicity, incidence / prevalence are undefined at this point"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-5",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#sites306363",
    "clean_content": "Sites\n\n* Typically presents with localized lymphadenopathy or a discrete mass* Common anatomical locations: mandible, cervical, supraclavicular, abdominal, retroperitoneal and oropharyngeal regions ([Adv Anat Pathol 2013;20:137](23574769))* Rare cases have shown disseminated multinodal involvement ([Am J Surg Pathol 2014;38:1298](24618611))* Does not involve mediastinum* Peripheral blood and bone marrow are not involved"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-6",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#clinicalfeatures306367",
    "clean_content": "Clinical features\n\n* Clinical presentation varies but patients are generally asymptomatic and healthy* Can be associated with other underlying neoplastic pathologic conditions, such as carcinomas, Castleman disease, follicular dendritic cell tumors and angioimmunoblastic T cell lymphoma ([Am J Surg Pathol 2012;36:1619](23060347))"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-7",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#diagnosis306368",
    "clean_content": "Diagnosis\n\n* Major criteria ([Adv Anat Pathol 2013;20:137](23574769)):\n  + No aberrant antigen expression (immunophenotype is of normal immature cortical thymocytes)+ Nonclonal TdT+ T cells+ No evidence of T cell gene rearrangements (TCR α and TCR β)+ Clinical evidence of indolence, > 6 months of follow up without progression in the absence of treatment"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-8",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#prognosticfactors306372",
    "clean_content": "Prognostic factors\n\n* Clinically indolent* May persist in the involved tissue"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-9",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#casereports306373",
    "clean_content": "Case reports\n\n* 35 year old man with indolent T lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease ([Pathology 2018;50:351](29486963))* 37 year old woman with an indolent T lymphoblastic proliferation involving the upper aerodigestive tract ([Int J Clin Exp Pathol 2014;7:6350](25337290))* 41 year old woman with pelvic pain found to have localized Castleman disease with concomitant iT-LBP ([Ann Pathol 2019;39:29](30554835))"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-10",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#treatment306374",
    "clean_content": "Treatment\n\n* Typical lesions show no signs of progression and require no treatment* Treatment for secondary disease (if present) may be needed"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-11",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#grossdescription306376",
    "clean_content": "Gross description\n\n* Typically forms a tumor mass, varies in size from ≤ 1 cm to ≥ 9 cm in greatest dimension* External surface may be firm and fibrous or nonencapsulated* Displays pink-tan firm fleshy cut surfaces* Necrotic (yellow) areas may be seen in cases associated with hepatocellular carcinoma (HCC)* Reference: [Adv Anat Pathol 2013;20:137](23574769)"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-12",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#microscopichistologicdescription306380",
    "clean_content": "Microscopic (histologic) description\n\n* Preservation of overall tissue architecture ([Adv Anat Pathol 2013;20:137](23574769))* Lymph nodes: benign lymphoblasts localize predominantly to interfollicular / paracortical regions* Carcinomas: lymphoblasts are interspersed or clustered between malignant epithelial cells without definitive evidence of lymphoepithelial lesions* Small to intermediate sized lymphoid cells with immature fine / blastoid chromatin lacking significant atypia* Inconspicuous nucleoli* Numerous mitotic figures may be present* Histiocytes are interspersed evenly throughout the proliferation"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-13",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#microscopichistologicimages306381",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Kunwar Singh, M.D. and Robert S. Ohgami, M.D., Ph.D.  \n\n[![Castleman disease](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh1.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh1.jpg)\n\nCastleman disease\n\n[![Follicular dendritic cell tumor](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh2.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh2.jpg)\n\nFollicular dendritic cell tumor\n\n[![CD1a](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh3.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh3.jpg)\n\nCD1a\n\n[![CD3](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh4.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh4.jpg)\n\nCD3\n\n  \n\n[![CD4](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh5.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh5.jpg)\n\nCD4\n\n[![CD8](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh6.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh6.jpg)\n\nCD8\n\n[![CD99](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh7.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh7.jpg)\n\nCD99\n\n[![TdT](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh8.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodestlymphoblasticMicroSingh8.jpg)\n\nTdT"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-14",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#cytologydescription306383",
    "clean_content": "Cytology description\n\n* Small to intermediate sized monotonous population with fine dispersed chromatin pattern and scant cytoplasm; occasional variably sized nucleoli may be present"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-15",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#positivestains306387",
    "clean_content": "Positive stains\n\n* Positive: [TdT](https://www.pathologyoutlines.com/topic/stainstdt.html), [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html), [CD43](https://www.pathologyoutlines.com/topic/cdmarkerscd43.html), [CD45RO](https://www.pathologyoutlines.com/topic/cdmarkerscd40.html#cd45ro286750)* Variable: [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html), [CD99](https://www.pathologyoutlines.com/topic/cdmarkerscd99.html), [CD1a](https://www.pathologyoutlines.com/topic/cdmarkerscd1a.html), [CD2](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd2288039), [CD5](https://www.pathologyoutlines.com/topic/cdmarkerscd5.html), [CD7](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd7288045), [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html)+ / [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)+ or [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html)- / [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)-* High [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html) index"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-16",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#negativestains306388",
    "clean_content": "Negative stains\n\n* [PAX5](https://www.pathologyoutlines.com/topic/stainspax5.html), [CD20](https://www.pathologyoutlines.com/topic/cdmarkerscd20.html), [CD79a](https://www.pathologyoutlines.com/topic/cdmarkerscd79a.html), [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html)* No thymic epithelium seen by immunostains"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-17",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Flow cytometry description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#flowcytometrydescription306389",
    "clean_content": "Flow cytometry description\n\n* Incidental benign [TdT](https://www.pathologyoutlines.com/topic/stainstdt.html)+ T cell populations may be detected by flow cytometry* Immunophenotype can show the entire range of T cell differentiation from the most immature dual [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html)- / [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)- / [CD7](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd7288045) bright+ / [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html)+ / cytoplasmic [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html)+ / surface [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html)- forms to surface [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html)+ forms with coexpression of [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html) and [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html) ([Cytometry B Clin Cytom 2020;98:282](31571375))* Proportion of T lymphoblasts (identified by cytoplasmic [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html) and [TdT](https://www.pathologyoutlines.com/topic/stainstdt.html) expression) can vary from < 1% of events to > 50% of events"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-18",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#molecularcytogeneticsdescription306393",
    "clean_content": "Molecular / cytogenetics description\n\n* iT-LBP have nonclonal T cell receptor (TCR) gene rearrangement studies (TCR γ or β)* No definitive chromosomal abnormalities* Initial reported case reported chromosome 9 inversion of uncertain significance ([Am J Surg Pathol 1999;23:977](10435569))"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-19",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#samplepathologyreport306396",
    "clean_content": "Sample pathology report\n\n* Lymph node, inguinal, excision:\n  + Castleman disease, hyaline vascular variant+ Indolent T lymphoblastic proliferation (see comment)+ Comment: Sections from the inguinal node show predominantly preserved nodal architecture with atretic follicles and increased vascularity with a subset of hyalinized vessels penetrating regressed germinal centers. Interspersed within the paracortical areas are increased CD3+ / TdT+ positive T cells without aberrant antigen expression. The presence of immature T cells in association with hyaline vascular Castleman disease has been reported and typically shows indolent behavior. Clinical correlation is recommended. ([Am J Surg Pathol 2012;36:1619](23060347))"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-20",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#differentialdiagnosis306397",
    "clean_content": "Differential diagnosis\n\n* [T lymphoblastic leukemia / lymphoma](https://www.pathologyoutlines.com/topic/leukemiaTall.html):\n  + Typically effaces nodal architecture or will infiltrate relatively nondiscriminately throughout entire node obliterating residual follicles+ Usually expresses [LMO2](https://www.pathologyoutlines.com/topic/stainslmo2.html) on malignant lymphoblasts ([Histopathology 2020;77:984](32526041))* [Ectopic thymic tissue](https://www.pathologyoutlines.com/topic/thyroidthymictissue.html):\n    + Residual thymic epithelium is also present and is highlighted by keratin stains: [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CAM5.2](https://www.pathologyoutlines.com/topic/stainscam52.html), [CK7](https://www.pathologyoutlines.com/topic/stainsck7.html)* [Thymoma](https://www.pathologyoutlines.com/topic/mediastinumthymoma.html):\n      + Lobulated architecture+ Presence of thymic epithelial meshworks+ No expression of [LMO2](https://www.pathologyoutlines.com/topic/stainslmo2.html) on lymphoblasts+ Presence in the mediastinum"
  },
  {
    "id": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt-21",
    "source_document": "indolent-t-lymphoblastic-proliferations_38631_1750165658.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodestlymphoblastic.html#additionalreferences306398",
    "clean_content": "Additional references\n\n* [Am J Surg Pathol 2018;42:1647](30222603)"
  }
]